Mizuho Medy Co.,Ltd.
Research Mizuho Medy Co.,Ltd. (4595.T) on Bullrun: market cap JPY 33.37B, P/E 10.3, dividend yield 5.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4595.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 33.37B
- P/E10.3
- Dividend yield5.8%
- Financial periodFY2025
- RevenueJPY 11.26B
- Revenue growth-1.5%
- Net incomeJPY 3.43B
- Free cash flowJPY 1.67B
- Gross margin69.4%
Valuation Snapshot
latest market cap is JPY 33.37B; P/E is 10.3; dividend yield is 5.8%.
Peer valuation comparison
Latest P/E is 10.34x versus a Healthcare sector median of 21.69x (52.3% below).
Latest dividend yield is 5.78% versus a Healthcare sector median of 2.41% (139.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 11.26B | JPY 3.43B | JPY 1.67B | 69.4% | 179.84 | JPY 10.83B | n/a | JPY 18.68B |
| FY2024 | JPY 11.43B | JPY 3.77B | JPY 3.05B | 70.7% | 198.12 | JPY 11.25B | n/a | JPY 17.35B |
| FY2023 | JPY 10.99B | JPY 3.77B | JPY 3.72B | 73.5% | 198.13 | JPY 10.13B | n/a | JPY 15.67B |
| FY2022 | JPY 17.58B | JPY 7.84B | JPY 5.99B | 80.2% | 411.47 | JPY 8.70B | n/a | JPY 14.28B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 33.37B | 10.3 | 5.7% | 100 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 100 JPY, yield 5.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 100 JPY |
| FY2024 | 100 JPY |
| FY2023 | 100 JPY |
| FY2022 | 125 JPY |
| FY2021 | 77.5 JPY |
About Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products, and related scientific and technical information services in Japan. The company offers molecular diagnostic products, such as nucleic acid amplification test products comprising gene analysis instruments and mycoplasma pneumoniae nucleic acid kits. It also provides rapid immunoassay products, including influenza virus antigen test kit; RS virus and human metapneumovirus antigen test kit;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mizuho Medy Co.,Ltd.'s market cap?
Mizuho Medy Co.,Ltd.'s market capitalization is JPY 33.37B.
What is Mizuho Medy Co.,Ltd.'s P/E ratio?
Mizuho Medy Co.,Ltd.'s price-to-earnings (P/E) ratio is 10.3.
Does Mizuho Medy Co.,Ltd. pay a dividend?
Mizuho Medy Co.,Ltd. has a dividend yield of 5.8%.
What does Mizuho Medy Co.,Ltd. do?
Mizuho Medy Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products, and related scientific and technical information services in Japan. The company offers molecular diagnostic products, such as nucleic acid amplification test products comprising gene analysis instruments and mycoplasma pneumoniae nucleic acid kits.